Speaker Profile
Ph.D., President, Shilpa Pharma
Biography
Harsh Bal brings cross value chain experience in the pharma, biotech, health and tech industry. He has held lead positions at Astellas Pharma, Takeda Oncology, Dana-FarberHarvard Cancer Center and Cold Spring Harbor Laboratory, where he trained in and applied high-throughput informatics, machine learning and functional genomics technologies for discovery RD across the immuno-oncology, infectious disease, cardiovascular and metabolic TAs. As a management consultant at Booz Allen Hamilton, Harsh played key roles in US National Cancer Institutes integrative cancer informatics program. He previously headed global strategy and business for Piramal Pharma Solutions and Syngene International to advance small and large molecule programs from IND to NDA to commercial for global biotech and pharma clients. Harsh has authored several peer-reviewed articles as well as books on biomedical informatics by Tata McGraw-Hill and Springer. He currently leads Shilpa Pharma's CDMO operations as President North America based out of the US.
Talk
NLP-Driven Automated Knowledge Generation and Marketplace Platform
The talk will provide a demo of an AI platform based on use cases from the industry in areas such as early-stage discovery, novel biomarker identification, protein-protein interaction, pathway analysis, pipeline gaps, and KOL identification.
AI for Emerging Therapeutics Showcase:
Shilpa Pharma, Inc.
The AI platform offers automated knowledge discovery, NLP driven insights, full translational views of drug R&D, deep mapping of knowledge assets to assist with early drug discovery.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI for Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies to explore the transformative role of artificial intelligence in accelerating the discovery, development, and optimization of novel therapeutic modalities. From predictive algorithms for drug efficacy to real-time analysis in clinical trials, AI is revolutionizing the way we approach emerging therapies, including RNA-based treatments, gene editing, and personalized medicine. Industry leaders and experts will discuss AI-driven advancements, collaborative frameworks, and the challenges of integrating cutting-edge technologies into therapeutic innovation. Join us for an in-depth look at how AI is shaping the future of breakthrough therapeutics.
